Clinical Trial

Feasibility Study of the FARAFLEX Mapping and PFA System

Study acronym: ELEVATE-PF
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this feasibility study is to evaluate the safety and effectiveness of the FARAFLEX mapping and pulsed field ablation (PFA) catheter, a novel catheter in treating persistent atrial fibrillation (PersAF) or symptomatic Paroxysmal Atrial Fibrillation (PAF).
Protocol Amendment History 22 amendments
This ClinicalTrials.gov record has been amended 22 times since 2024-07-15; most recent amendment 2026-07-24.
Status change: Not Yet Recruiting → Recruiting 2025-02-20
Trial Details
NCT Number NCT06510556
Lead Sponsor Boston Scientific Corporation
Conditions Atrial Fibrillation, Persistent Atrial Fibrillation, Paroxysmal AF
Enrollment 250 participants
Start Date 2025-02-17
Primary Completion 2027-02-15 (estimated)
Study Completion 2027-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-27